Compare IDEXX Laboratories, Inc. (IDXX) vs IAC/Interactivecorp (PPLI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
IDEXX Laboratories, Inc. vs IAC/Interactivecorp — how do they compare? IDEXX Laboratories, Inc. trades at $558.08 (market cap $44.48B), while IAC/Interactivecorp trades at $44.29 (market cap $3.32B). The key difference: IDEXX Laboratories, Inc. is far larger — about 13.4× IAC/Interactivecorp's market cap, and IAC/Interactivecorp is trading nearer its 52-week high, IDEXX Laboratories, Inc. nearer its low. Which is the better fit depends on your goals.
| IDXX | PPLI | |
|---|---|---|
Market Cap | $44.48B | $3.32B |
Sector | Health | Media |
52-Week High | $766.68 | $47.62 |
52-Week Low | $520.87 | $31.52 |
Enterprise Value | $45.38B | $3.63B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
IDXX trades at $563.79, down 0.64% today but maintains strong fundamental momentum with consistent earnings beats and robust profitability. The stock shows bullish technical signals with support at $563 and resistance at $572, while valuation metrics remain elevated. Recent Q1 2026 results exceeded expectations with EPS of $3.47 versus $3.41 estimates, supporting the company's leadership in veterinary diagnostics.
Outlook remains positive given strong analyst support (59% buy ratings) and innovation pipeline, though premium valuations and competitive pressures present risks. Revenue growth trajectory and expanding margins provide fundamental support for continued upside potential in the pet healthcare sector.
PPLI trades at $44.71, up 0.4% today, with a bullish technical signal from moving averages and oversold short-term RSI. Recent quarters show earnings misses, but revenue stabilized near $2.4B in 2025. The stock trades below book value (P/B 0.73) and carries a consensus price target of $55.40. News highlights potential MGM acquisition talks and Q2 2026 earnings call scheduled for August 4th.
Outlook is mixed: strong analyst buy ratings (64%) and undervaluation signals support upside, but persistent net losses and volatile cash flows pose risks. Investors should weigh the discount to NAV against execution challenges in achieving profitability.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About IDEXX Laboratories, Inc.
Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx gets about 38% of its revenue from outside the United States.
Read more on IDXX →About IAC/Interactivecorp
IAC Inc is an Internet media company with segments that include Angi (47% of total revenue), Dotdash (10%), search (24%), and emerging and other (19%). The firm spun off the narrow-moat dating app provider Match Group in second-quarter 2020 and the no-moat video software provider Vimeo in second-quarter 2021.
Read more on PPLI →
